Richard Glickman
Chairman at ESSA PHARMA INC.
Net worth: 647 966 $ as of 2024-04-29
Network origin in Richard Glickman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 31 | |
| Public Company | Pharmaceuticals: Major | 21 | |
| Public Company | Biotechnology | 16 | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.
16
| Subsidiary | Investment Managers | 16 |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.
14
| Subsidiary | Biotechnology | 14 |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada.
14
| Extinct | Pharmaceuticals: Major | 14 |
| Public Company | Biotechnology | 11 | |
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation.
3
| Private Company | Medical Specialties | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Richard Glickman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of British Columbia | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree Doctorate Degree | |
| McGill University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Alberta | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Queen's University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Masters Business Admin | |
| Richard Ivey School of Business | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
| LAVA MEDTECH ACQUISITION CORP. | Financial Conglomerates | President Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO Corporate Secretary Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Isotechnika, Inc.
 Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Seoul National University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| University of Cape Town | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| Accuro Technologies, Inc. | Director/Board Member Chairman Chief Executive Officer | ||
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Founder Founder Director/Board Member | |
| MANY BRIGHT IDEAS TECHNOLOGIES INC. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Biotechnology | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| University of Toronto | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
| REALM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
| University of California San Diego | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| INMED PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member President | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| University of Calgary | College/University | Undergraduate Degree Doctorate Degree | |
Cardiac Dimensions, Inc.
 Cardiac Dimensions, Inc. Medical SpecialtiesHealth Technology Cardiac Dimensions, Inc. develops novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. It offers the CARILLON Mitral Contour System, a proprietary and implantable device designed to be positioned in the coronary sinus vein using cardiac catheterization techniques. The firm also offers patient enrollment, clinical testing, and medical consulting services. The company was founded by James W. Fitzsimmons and Scott Jordan Wolf in 2001 and is headquartered in Kirkland, WA. | Medical Specialties | Director/Board Member Director/Board Member | |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Chairman Director/Board Member | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Groningen | College/University | Graduate Degree Doctorate Degree | |
| TRANSLATE BIO, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| 89BIO, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Graduate Degree Doctorate Degree | |
| ZYMEWORKS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Graduate Degree | |
| St. Joseph's University | College/University | Masters Business Admin Undergraduate Degree | |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of South Carolina | College/University | Undergraduate Degree Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree |
Statistics
International
| United States | 29 |
| Canada | 16 |
| Netherlands | 3 |
| Hong Kong | 2 |
| South Korea | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 21 |
| Commercial Services | 4 |
| Finance | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 595 |
| Corporate Officer/Principal | 230 |
| Independent Dir/Board Member | 155 |
| Chairman | 80 |
| Chief Executive Officer | 79 |
Most connected contacts
| Insiders | |
|---|---|
| Franklin Berger | 41 |
| Dennis Langer | 40 |
| Paul Geyer | 37 |
| Otello Stampacchia | 37 |
| Kurt von Emster | 34 |
| Brian Underdown | 34 |
| Peter Greenleaf | 31 |
| David Parkinson | 31 |
| Michael Hayden | 27 |
| R. MacKay-Dunn | 26 |
| Charles Rowland | 25 |
| Peter van der Velden | 25 |
| Gerry Brunk | 25 |
| George Milne | 24 |
| Scott Requadt | 23 |
- Stock Market
- Insiders
- Richard Glickman
- Company connections
